Research & Development

Pharmotech SA focuses its Research and Development (R&D) in the phytopharma world,  especially on their possible pharmacological applications. We have the best and vastest laboratory just around us: Nature. It is fascinating for us to re-discover its secrets. Switzerland is a country with several positive facets, being one of them its ... to read more click here.

PHARMOTECH’S PATENT (IP)

Title: CANNABIDIOL COMPOSITIONS AND USES THEREOF

.
Abstract: The present invention is directed to use of cannabidiol and compositions thereof as an anti- bacterial agent against multi-drug resistant bacteria such as Pseudomonas aeruginosa.
.
Priority Data: 02.06.2016
Publication Number: WO/2017/207730
International Application: No.PCT/EP2017/063385
International Filing Date: 01.06.2017
.

Granted countries: USA, CINA, RUSSIA, INDIA, EUROPE, ARIPO, OAPI, UK SWITZERLAND, MEXICO, CHILE...

Claims:

1. CBD or a composition thereof for use in the prevention and/or treatment of a disease caused by P. aeruginosa bacteria.

2. CBD or a composition thereof for use according to claim 1 wherein said disease or disorder is selected from the group consisting of hospital-acquired infection, respiratory tract infections, skin and soft tissue infections, wound infections, dental and buccal infections, otorhinolaryngologic infections, urological and/or prostatic track infections, gastrointestinal infections, biliary tract infection, eye infections, bacteremia, sepsis, central nervous system infections and endocarditis.

3. Use of CBD or a composition thereof for sterilizing and/or decontaminating medical material, rooms intended for medical, aesthetic or hygiene practice or preparations intended for human or veterinary use.

4. Use according to claim 3, for decontaminating or preventing said medical material or preparations from P. aeruginosa contamination.

5. Use of CBD or a composition thereof according to claim 4, wherein said preparation is selected from a cosmetic preparation, food, meal preparation and beverage.

6. Use of CBD or a composition thereof according to claim 4, as a sterilizing and/or decontamination agent for medical, hospital or clean rooms.

7. Use of CBD or a composition thereof according to claim 4, as a sterilizing and/or decontamination agent for medical material.

8. Use of CBD or a composition thereof for conservation of work of art.

9. A decontaminating or sterilizing composition comprising CBD at a concentration between about 0.1 μg/mL to 200 mg/mL, such as from 0.1 μg/mL to 1 mg/mL and a further physiologically acceptable carrier, diluent or excipient.

10. A food, beverage or a cosmetic preparation comprising CBD or a composition thereof as preservative or sterilizing agent of said preparation at a concentration between about 0.1 μg/mL to 200 mg/mL, such as from 0.1 μg/mL to 1 mg/mL.

11. An article coated with CBD or a composition thereof.

12. A kit for material surface or solution decontamination or sterilizing comprising CBD or a composition thereof, and optionally instructions for use.

13. A kit according to claim 12, wherein CBD is at a concentration between about 0.1 μg/mL to 200 mg/mL, such as from 0.1 μg/mL to 1 mg/mL.

14. A method of sterilisation and/or decontamination of medical material, rooms intended for medical, aesthetic or hygiene practice or preparations intended for human or veterinary use comprising the step of contacting said material, room or preparations with CBD, or a composition thereof.

15. An ex vivo method of inhibiting virulence of P. aeruginosa bacteria and/or bio film formation by said bacteria, said method comprising the step of contacting a material or a solution containing said bacteria and/or bio film thereof with CBD, or a composition thereof.

16. A method according to claim 15 wherein the CBD composition is a decontaminating or sterilizing composition according to claim 9.

17. A method for conservation of work of art, such as paintings and antique manuscripts comprising the step of contacting said work of art with CBD, or a composition thereof.

18. A method according to claim 17 wherein the CBD composition is a decontaminating or sterilizing composition according to claim 9.

19. A method for preventing and/or treating of a disease caused by P. aeruginosa bacteria, in particular a disease or disorder selected from the group consisting of hospital- acquired infection, respiratory tract infections, skin and soft tissue infections, wound infections, dental and buccal infections, otorhinolaryngologic infections, urological and/or prostatic track infections, gastrointestinal infections, biliary tract infection, eye infections, bacteremia, sepsis, central nervous system infections and endocarditis, said method comprising administering a therapeutically effective amount of CBD, or a composition thereof according to the invention, to a subject in need thereof.

Source: Patentscope

PSEUDOMONAS AERUGINOSA

WHAT IS PSEUDOMONAS AERUGINOSA?

Pseudomonas aeruginosa is a Gram negative bacteria that is commonly found in the environment e.g. soil, water and other moist locations

WHAT DISEASES ARE CAUSED BY PSEUDOMONAS AERUGINOSA?

Pseudomonas aeruginosa is an opportunistic pathogen. The bacteria takes advantage of an individual's weakened immune system to create an infection and this organism also produces tissue-damaging toxins. Pseudomonas aeruginosa causes urinary tract infections, respiratory system infections, dermatitis, soft tissue infections, bacteremia, bone and joint infections, gastrointestinal infections and ... click to read more